Tiziana Other Operating Expenses vs Research Development Analysis
| TLSA Stock | USD 0.92 0.03 3.16% |
Tiziana Life financial indicator trend analysis is much more than just breaking down Tiziana Life Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tiziana Life Sciences is a good investment. Please check the relationship between Tiziana Life Other Operating Expenses and its Research Development accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tiziana Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Other Operating Expenses vs Research Development
Other Operating Expenses vs Research Development Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tiziana Life Sciences Other Operating Expenses account and Research Development. At this time, the significance of the direction appears to have strong relationship.
The correlation between Tiziana Life's Other Operating Expenses and Research Development is 0.73. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Research Development in the same time period over historical financial statements of Tiziana Life Sciences, assuming nothing else is changed. The correlation between historical values of Tiziana Life's Other Operating Expenses and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Tiziana Life Sciences are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Other Operating Expenses i.e., Tiziana Life's Other Operating Expenses and Research Development go up and down completely randomly.
Correlation Coefficient | 0.73 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Tiziana Life Sciences. It is also known as Tiziana Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Research Development
Most indicators from Tiziana Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tiziana Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tiziana Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. At present, Tiziana Life's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 148.56, whereas Selling General Administrative is forecasted to decline to 0.00.
Tiziana Life fundamental ratios Correlations
Click cells to compare fundamentals
Tiziana Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tiziana Life fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 2.4M | 70.5M | 48.8M | 26.5M | 12.2M | 10.9M | |
| Other Current Liab | 82.6K | 4.3M | 3.1M | 1.6M | 2.3M | 2.4M | |
| Total Current Liabilities | 7.3M | 8.0M | 7.5M | 6.7M | 6.5M | 6.9M | |
| Total Stockholder Equity | (5.5M) | 62.3M | 41.3M | 19.6M | 5.5M | 8.2M | |
| Property Plant And Equipment Net | 437.9K | 358.4K | 17K | 389K | 293K | 307.7K | |
| Net Debt | 616.2K | (65.2M) | (40.8M) | (17.8M) | (936K) | (982.8K) | |
| Retained Earnings | (56.6M) | (84.9M) | (108.1M) | (116.3M) | (133.7M) | (127.0M) | |
| Accounts Payable | 6.4M | 3.4M | 4.4M | 5.0M | 4.1M | 4.3M | |
| Cash | 200.6K | 65.7M | 42.2M | 18.1M | 1.2M | 1.1M | |
| Non Current Assets Total | 870.6K | 490.6K | 147K | 2.2M | 4.8M | 5.1M | |
| Non Currrent Assets Other | 5.5K | 283.0K | 120K | 130K | 149.5K | 157.0K | |
| Cash And Short Term Investments | 200.6K | 65.7M | 42.2M | 18.1M | 1.2M | 1.1M | |
| Common Stock Total Equity | 3.8M | 6.8M | 4.1M | 10.8M | 12.4M | 6.2M | |
| Common Stock Shares Outstanding | 136.5M | 169.1M | 97.9M | 101.5M | 91.4M | 86.8M | |
| Liabilities And Stockholders Equity | 2.4M | 70.5M | 48.8M | 26.5M | 12.2M | 10.9M | |
| Other Current Assets | 1.3M | 568K | 1.2M | 300K | 102K | 96.9K | |
| Other Stockholder Equity | 32.9M | 146.9M | 30.1M | 20.2M | 22.0M | 22.0M | |
| Total Liab | 7.9M | 8.3M | 7.5M | 6.9M | 6.6M | 7.0M | |
| Property Plant And Equipment Gross | 334K | 360K | 77K | 389K | 293K | 307.7K | |
| Total Current Assets | 1.5M | 70.1M | 48.7M | 24.3M | 7.3M | 9.1M | |
| Common Stock | 5.2M | 5.4M | 8.0M | 102K | 103K | 97.9K | |
| Accumulated Other Comprehensive Income | 12.8M | (38.3M) | 119.2M | 115.6M | 117.1M | 122.9M | |
| Short Long Term Debt Total | 816.9K | 554.7K | 1.4M | 365K | 247K | 372.4K | |
| Current Deferred Revenue | 591.3K | 4.3M | (1.4M) | 2.3M | 2.6M | 2.7M | |
| Short Term Debt | 278.0K | 265K | 1.4M | 122K | 138K | 131.1K | |
| Net Receivables | 1.3M | 3.8M | 5.3M | 6.0M | 6.1M | 6.4M | |
| Inventory | (1.3M) | 564.9K | (5.3M) | (6.0M) | (5.4M) | (5.1M) | |
| Non Current Liabilities Total | 538.9K | 288.9K | 4.4M | 243K | 109K | 103.6K | |
| Net Tangible Assets | (5.5M) | 62.4M | 41.2M | 19.6M | 22.5M | 16.9M | |
| Property Plant Equipment | 439K | 360K | 17K | 389K | 447.4K | 469.7K | |
| Net Invested Capital | (4.2M) | 62.4M | 41.3M | 19.6M | 5.5M | 5.3M | |
| Net Working Capital | (4.4M) | 62.2M | 41.1M | 17.6M | 798K | 758.1K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tiziana Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tiziana Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tiziana Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tiziana Life Sciences Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tiziana Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tiziana Life. If investors know Tiziana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tiziana Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.13) | Revenue Per Share (0.02) | Return On Assets (0.70) | Return On Equity (1.81) |
The market value of Tiziana Life Sciences is measured differently than its book value, which is the value of Tiziana that is recorded on the company's balance sheet. Investors also form their own opinion of Tiziana Life's value that differs from its market value or its book value, called intrinsic value, which is Tiziana Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tiziana Life's market value can be influenced by many factors that don't directly affect Tiziana Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tiziana Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tiziana Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tiziana Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.